MD Anderson and United Healthcare bring experiments with bundled payment models in cancer care to a new area: head and neck cancers.
In 2010, UnitedHealthcare launched a pilot project to move away from fee-for-service payments in cancer care, involving 810 patients with lung, breast and colorectal cancer who were treated in 5 groups of medical oncology throughout the United States.
Based on those results, which were reported in this summer in the Practical Oncology Journal, and found that cancer costs were reduced by a third while quality improved, UnitedHealthcare is ready to try again, this time at the University of Texas’ MD Anderson Cancer Center, and with a different type of disease: head and neck cancer.
The so-called “bundled” payment model program will last 3 years, and will capture payments for surgery, radiation and chemotherapy in a single fee rather than multiple payments, which research shows can cost more and be less efficient.
United Healthcare believes that prepricing the payment will give both patients and doctors a better idea of costs from the start, and that doctors will end up being paid more because they will work to eliminate unnecessary tests and steps.
To launch the pilot, 8 different payment models were developed based on years of experience between MD Anderson and UnitedHealthcare. “Our partnership with MD Anderson Cancer Center marks an important step toward expanded bundled care payment models and away from the traditional fee-for-service payments for oncology care,” said Lee N. Newcomer, M.D., United Healthcare’s vice president, oncology.
“Our recently completed pilot shows that these creative new cancer care payment models can reduce health care costs while improving patient outcomes. MD Anderson’s work with value-based workflows makes them a natural partner for bundled payments.”
In an interview with Forbes, Dr Newcomer said doctors will have more certainty, because “they are going to know right upfront what the total cost is.”
The concept of the bundled payment has received mixed reviews in recent years, but more providers appear willing to give it a try. In a 2013 report to Evidence-Based Oncology, a publication of The American Journal of Managed Care, commentator Kurt Ullman wrote that only strong, efficient practices would be able to function under this type of reimbursement system, and less efficient practices would fail.
Around the Web
MD Anderson, United Healthcare Cancer Care Payment Model
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Understanding How Fitness Affects Digestive Diseases
April 18th 2025Exercise is a powerful modulator of gut health in patients with gastrointestinal (GI) conditions, as moderate activity can ease gut inflammation, reduce colorectal cancer risk, and relieve constipation, while intense workouts may backfire, causing reflux, GI bleeding, or gut barrier disruption.
Read More
FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade
April 18th 2025Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives and itching remain uncontrolled by antihistamines.
Read More